Clinical Trial Update: Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating apalutamide and abiraterone acetate in African American and Caucasian men with metastatic castration-resistant prostate cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)
• Zytiga (abiraterone acetate)

Snippet

Sponsor: Daniel George, MD | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-09-12